Literature DB >> 17728224

An active TRIM5 protein in rabbits indicates a common antiviral ancestor for mammalian TRIM5 proteins.

Torsten Schaller1, Stéphane Hué, Greg J Towers.   

Abstract

The recent identification of antiretroviral tripartite motif-bearing restriction factors that protect against retroviral infection has revealed a novel branch of innate immunity. The factors target the retroviral capsid and inhibit infectivity soon after the capsid has entered the cytoplasm by an incompletely characterized mechanism. Restriction is species specific. For example, TRIM5alpha from Old World monkeys, but not humans, restricts human immunodeficiency virus type 1 infection. Here, we identify an antiviral TRIM5 molecule in rabbits that is closely related to antiviral TRIM5 of both primates and cattle. We demonstrate that the rabbit TRIM5 protein is active against divergent retroviruses and leads to a strong block to viral DNA synthesis and infectivity. Furthermore, we show that antiviral activity is directed against the viral capsid and that human TRIM5 proteins are dominant negative to restriction in rabbit cells. We propose that the sequence and restriction characteristics conserved between restriction factors from primates, cattle, and rabbits indicate that these factors have evolved from a common ancestor with antiretroviral properties.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17728224      PMCID: PMC2168759          DOI: 10.1128/JVI.01468-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

1.  A conserved mechanism of retrovirus restriction in mammals.

Authors:  G Towers; M Bock; S Martin; Y Takeuchi; J P Stoye; O Danos
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

2.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

3.  The major human immunodeficiency virus type 2 (HIV-2) packaging signal is present on all HIV-2 RNA species: cotranslational RNA encapsidation and limitation of Gag protein confer specificity.

Authors:  S D Griffin; J F Allen; A M Lever
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Episodic evolution of pyrin in primates: human mutations recapitulate ancestral amino acid states.

Authors:  P Schaner; N Richards; A Wadhwa; I Aksentijevich; D Kastner; P Tucker; D Gumucio
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

5.  Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression.

Authors:  C Tissot; N Mechti
Journal:  J Biol Chem       Date:  1995-06-23       Impact factor: 5.157

6.  Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells.

Authors:  D Nègre; P E Mangeot; G Duisit; S Blanchard; P O Vidalain; P Leissner; A J Winter; C Rabourdin-Combe; M Mehtali; P Moullier; J L Darlix; F L Cosset
Journal:  Gene Ther       Date:  2000-10       Impact factor: 5.250

7.  All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction.

Authors:  Sadayuki Ohkura; Melvyn W Yap; Tom Sheldon; Jonathan P Stoye
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

8.  The design of artificial retroviral restriction factors.

Authors:  Melvyn W Yap; Gulnahar B Mortuza; Ian A Taylor; Jonathan P Stoye
Journal:  Virology       Date:  2007-05-09       Impact factor: 3.616

9.  HIV-2 and SIV infection of nonprimate cell lines expressing human CD4: restrictions to replication at distinct stages.

Authors:  A McKnight; P R Clapham; R A Weiss
Journal:  Virology       Date:  1994-05-15       Impact factor: 3.616

Review 10.  The control of viral infection by tripartite motif proteins and cyclophilin A.

Authors:  Greg J Towers
Journal:  Retrovirology       Date:  2007-06-12       Impact factor: 4.602

View more
  51 in total

1.  Human Trim5α has additional activities that are uncoupled from retroviral capsid recognition.

Authors:  Semih U Tareen; Michael Emerman
Journal:  Virology       Date:  2010-10-28       Impact factor: 3.616

Review 2.  Host restriction factors blocking retroviral replication.

Authors:  Daniel Wolf; Stephen P Goff
Journal:  Annu Rev Genet       Date:  2008       Impact factor: 16.830

Review 3.  Retroviral restriction and dependency factors in primates and carnivores.

Authors:  Hind J Fadel; Eric M Poeschla
Journal:  Vet Immunol Immunopathol       Date:  2011-06-12       Impact factor: 2.046

Review 4.  An overview of the lagomorph immune system and its genetic diversity.

Authors:  Ana Pinheiro; Fabiana Neves; Ana Lemos de Matos; Joana Abrantes; Wessel van der Loo; Rose Mage; Pedro José Esteves
Journal:  Immunogenetics       Date:  2015-09-23       Impact factor: 2.846

Review 5.  Molecular evolution of the antiretroviral TRIM5 gene.

Authors:  Welkin E Johnson; Sara L Sawyer
Journal:  Immunogenetics       Date:  2009-02-24       Impact factor: 2.846

6.  An expanded clade of rodent Trim5 genes.

Authors:  Semih U Tareen; Sara L Sawyer; Harmit S Malik; Michael Emerman
Journal:  Virology       Date:  2009-01-15       Impact factor: 3.616

7.  Peripheral benzodiazepine receptor/translocator protein global knock-out mice are viable with no effects on steroid hormone biosynthesis.

Authors:  Lan N Tu; Kanako Morohaku; Pulak R Manna; Susanne H Pelton; W Ronald Butler; Douglas M Stocco; Vimal Selvaraj
Journal:  J Biol Chem       Date:  2014-06-16       Impact factor: 5.157

8.  Independent evolution of an antiviral TRIMCyp in rhesus macaques.

Authors:  Sam J Wilson; Benjamin L J Webb; Laura M J Ylinen; Ernst Verschoor; Jonathan L Heeney; Greg J Towers
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

9.  Porcine endogenous retroviruses PERV A and A/C recombinant are insensitive to a range of divergent mammalian TRIM5alpha proteins including human TRIM5alpha.

Authors:  Andrew Wood; Benjamin L J Webb; Birke Bartosch; Torsten Schaller; Yasuhiro Takeuchi; Greg J Towers
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

Review 10.  Human cellular restriction factors that target HIV-1 replication.

Authors:  Klaus Strebel; Jeremy Luban; Kuan-Teh Jeang
Journal:  BMC Med       Date:  2009-09-16       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.